Carcinoma, Hepatocellular: all 3,249 studies
Page 4 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B VirusNot yet recruitingNCT07088133Not applicable
- Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University HospitalsEnrolling by invitationNCT07088081
- Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort StudyRecruitingNCT07079150
- Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line TreatmentNot yet recruitingNCT07078305Phase 2
- The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world StudyNot yet recruitingNCT07078292
- Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver ResectionNot yet recruitingNCT07077798Not applicable
- WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical TherapyNot yet recruitingNCT07077369Phase 1
- Application of mRNA Vaccine in Liver Transplantation for Hepatocellular CarcinomaRecruitingNCT07077356Phase 1
- JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment FailureNot yet recruitingNCT07075419Phase 1/2
- Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular CancerRecruitingNCT07075120Phase 1
- Study of GV20-0251 in Participants With Solid Tumor MalignanciesRecruitingNCT07070518Phase 1/2
- Digital Early Warning System for Acute Lung Injury in Liver SurgeryRecruitingNCT07070362
- A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular CarcinomaRecruitingNCT07070076Not applicable
- Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective StudyNot yet recruitingNCT07064668Phase 2
- Safety and Clinical Efficacy of Histotripsy for Liver Cancers Adjacent to Major Intrahepatic VesselsNot yet recruitingNCT07063771Not applicable
- BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or OligometastasesRecruitingNCT07062055Phase 2
- Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)RecruitingNCT07059936
- Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver TransplantRecruitingNCT07059494Phase 4
- Downstaging Prediction Model for HCCNot yet recruitingNCT07058649
- The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver LesionsNot yet recruitingNCT07055048
- The Efficacy of Sequential RT After Triple Therapy for uHCCEnrolling by invitationNCT07052448
- A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.RecruitingNCT07052253Phase 2
- Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and BevacizumabRecruitingNCT07047586Phase 2
- Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue BiopsyEnrolling by invitationNCT07046832Not applicable
- Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver CancerRecruitingNCT07042919Phase 1/2
- AI-Driven Quantitative Decision and Surgical Planning System for Liver CancerEnrolling by invitationNCT07042841
- Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in FranceNot yet recruitingNCT07038863Not applicable
- Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular CarcinomaRecruitingNCT07036874
- Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.RecruitingNCT07027436Phase 3
- PSMA PET for the Staging and Management of Hepatocellular CarcinomaRecruitingNCT07019844
- PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular CarcinomaRecruitingNCT07018518Phase 1
- Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular CarcinomaRecruitingNCT07014150Phase 2
- FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular CarcinomaRecruitingNCT07012798Phase 2
- Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High RiskNot yet recruitingNCT07010588Not applicable
- A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular CarcinomaRecruitingNCT07010497Phase 2
- Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan CityRecruitingNCT07010198
- ctDNA Monitoring in Patients With HCC and mCRCRecruitingNCT07001085Not applicable
- [68Ga]Ga-PSMA PET/CT in Hepatocellular Carcinoma: Impact of Multiparametric Dynamic Whole-body Imaging and Kinetic Modeling.RecruitingNCT06999837Not applicable
- Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCCRecruitingNCT06999707Phase 2
- Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCCRecruitingNCT06999694Phase 2
- Impact of Comprehensive Geriatric Management on Morbidity and Quality of Life in Elderly Patients Undergoing Major Hepatectomy and Pancreaticoduodenectomy for CancerNot yet recruitingNCT06999512Phase 2/3
- Multiparametric MRI for Characterization of Hepatocellular CarcinomaRecruitingNCT06999174
- The Vanguard Study: Testing a New Way to Screen for CancerRecruitingNCT06995898Not applicable
- Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular CarcinomaRecruitingNCT06995105Phase 1/2
- Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular CarcinomaNot yet recruitingNCT06994572Phase 1
- Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)RecruitingNCT06990659Not applicable
- TACE Plus Ivonescimab for Unresectable Non-Metastatic HCCNot yet recruitingNCT06990620Phase 1
- A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCCNot yet recruitingNCT06984718Phase 2
- Streamlining Radioembolization for Small HCCRecruitingNCT06979219
- FGF19 Overexpression Combination Unified Study in HCC-19RecruitingNCT06978933Phase 2
- Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)Not yet recruitingNCT06972758Phase 2
- Evaluation of Skin Tests in Biotherapy AllergiesRecruitingNCT06971848Not applicable
- SIRT and Peri-immunotherapy : a New ConceptNot yet recruitingNCT06971237
- Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular CarcinomaRecruitingNCT06961617Phase 1
- Esophageal Varices Prophylaxis in Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabRecruitingNCT06961526Not applicable
- PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular CarcinomaRecruitingNCT06960954
- Fibroscan Evaluating Immunotherapy Response in Hepatocellular CarcinomaRecruitingNCT06960863
- Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of RecurrenceNot yet recruitingNCT06958484Phase 2
- JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular CarcinomaRecruitingNCT06954467Phase 2
- Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of RecurrenceRecruitingNCT06954116Phase 2
- DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsRecruitingNCT06953089Phase 2
- Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular CarcinomaRecruitingNCT06950827
- Same-day Radioembolization for Large HCCRecruitingNCT06944483
- Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled TrialRecruitingNCT06938945Not applicable
- Relationship Between FGF19 Overexpression and Disease PrognosisNot yet recruitingNCT06938451
- A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular CancerNot yet recruitingNCT06935175Phase 2
- A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence RiskRecruitingNCT06930573Phase 4
- Organoid Models of Hepatocellular CarcinomaRecruitingNCT06929845Not applicable
- Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)Not yet recruitingNCT06928415
- Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical TreatmentNot yet recruitingNCT06923176Phase 4
- Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaRecruitingNCT06921785Phase 3
- Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsRecruitingNCT06915753Phase 1
- Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular CarcinomaRecruitingNCT06911255Phase 1/2
- SH-LPS System in Preoperative Planning for Liver ResectionNot yet recruitingNCT06911086Phase 2/3
- IDOV-Immune for Advanced Solid TumorsRecruitingNCT06910657Phase 1
- SIRT Versus cTACE for Unresectable HCC (CHANCE2506)RecruitingNCT06909708Not applicable
- Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)RecruitingNCT06905262
- Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCCRecruitingNCT06904196Phase 2
- Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTTRecruitingNCT06904183Phase 2
- Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular CarcinomaRecruitingNCT06904170Phase 2/3
- The Epidemiology of Patients Treated With ATZ+BEV in Real Life SettingNot yet recruitingNCT06903663
- Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCCNot yet recruitingNCT06900478Phase 2
- HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerRecruitingNCT06899152Not applicable
- TACE Combined Surgery for the Resectable Huge HCCRecruitingNCT06898398
- Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT06896396Phase 1/2
- Retrospective Clinical Validation of HepatoPredictNot yet recruitingNCT06894524
- Individualized Comprehensive Treatment for Advanced Hepatocellular CarcinomaRecruitingNCT06893887Not applicable
- A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3RecruitingNCT06887348
- Impact of Radiotherapy on ctDNA in Patients With Hepatocellular CarcinomaRecruitingNCT06885879
- An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with LenvatinibNot yet recruitingNCT06884982Phase 2
- A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.RecruitingNCT06883539Phase 1
- JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib StudyEnrolling by invitationNCT06882876Phase 1
- STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular CarcinomaRecruitingNCT06880523Phase 2
- On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver CancerRecruitingNCT06877637
- Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCCRecruitingNCT06876753
- Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular CarcinomaRecruitingNCT06873269
- Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals TherapyNot yet recruitingNCT06872047
- Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver DiseaseNot yet recruitingNCT06871930
- Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 TherapyRecruitingNCT06870942Phase 2
- Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular CarcinomaNot yet recruitingNCT06867432Phase 2